Almotriptan adverse reactions: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Almotriptan}} {{CMG}}; {{AE}} {{PB}} ==Adverse Reactions== ==References== {{Reflist|2}} Category:AntiMigaraineDrugs Category:Drugs") |
No edit summary |
||
| Line 5: | Line 5: | ||
==Adverse Reactions== | ==Adverse Reactions== | ||
The most common adverse reactions (≥1% and greater than placebo) are: | |||
* In adults: nausea, dry mouth and paresthesia | |||
* In adolescents: dizziness, somnolence, headache, paresthesia, nausea and vomiting | |||
| Line 12: | Line 15: | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Drugs]] | [[Category:Drugs]] | ||
Revision as of 02:07, 5 February 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]
Adverse Reactions
The most common adverse reactions (≥1% and greater than placebo) are:
- In adults: nausea, dry mouth and paresthesia
- In adolescents: dizziness, somnolence, headache, paresthesia, nausea and vomiting